Table 1. Selected characteristics of the prostate cancer patient cohort.
| Characteristic | N (%) |
|---|---|
| Age (y) at diagnosis | |
| 35-49 | 71 (12.5) |
| 50-54 | 104 (18.4) |
| 55-59 | 138 (24.4) |
| 60-64 | 164 (29.0) |
| 65-69 | 57 (10.1) |
| 70-74 | 32 (5.6) |
| Race | |
| European- American | 519 (91.7) |
| African-American | 47 (8.3) |
| BMI | |
| <25 | 180 (31.8) |
| 25-29.9 | 286 (50.5) |
| 30+ | 100 (17.7) |
| Pathological Stage | |
| Localized | 390 (68.9) |
| Regional | 176 (31.1) |
| Gleason Sum | |
| 2-6 | 276 (48.8) |
| 7 (3+4) | 202 (35.7) |
| 7 (4+3)-10 | 88 (15.5) |
| PSA at diagnosis (ng/mL) | |
| 0-3.9 | 82 (14.5) |
| 4-9.9 | 338 (59.7) |
| 10-19.9 | 76 (13.4) |
| 20+ | 35 (6.2) |
| Missing | 35 (6.2) |
| Recurrence | |
| No | 341 (60.3) |
| Yes | 119 (21) |
| Unknown | 106 (18.7) |
| Vital Status | |
| Alive | 495 (87.5) |
| Prostate cancer death | 13 (2.3) |
| Other cause of death | 53 (9.3) |
| Unknown cause of death | 5 (0.9) |